Chemours partners with Navin Fluorine on cooling fluid

WILMINGTON, Del. - The Chemours Company (NYSE: CC), a global chemistry company with a market capitalization of $1.8 billion and annual revenue of $5.78 billion, has announced a strategic partnership with Navin Fluorine International Limited (NSE: NAVINFLUOR) to produce Opteon™, a two-phase immersion cooling fluid designed for advanced data centers and AI hardware. According to InvestingPro analysis, Chemours is currently trading below its Fair Value, suggesting potential upside opportunity. This collaboration, set to begin in 2026, is expected to address the increasing thermal management needs due to the rise of AI and next-generation chips.

Chemours’ Liquid Cooling Venture, which focuses on providing solutions for the heat, energy, and water demands of modern data centers, will leverage the new partnership to accelerate the commercialization of Opteon™. The company’s proprietary cooling fluid boasts an ultra-low global warming potential (10), a power usage effectiveness (PUE) near 1, and performance superiority over traditional cooling methods. It promises to nearly eliminate water usage, reduce space requirements by 60%, and lower energy consumption by up to 40%, with cooling energy use potentially dropping by up to 90%.

Denise Dignam, President and CEO of Chemours, emphasized the necessity of integrated solutions for AI’s computing demands, stating that their expertise in cooling is vital for bridging the gap. Vishad Mafatlal, Executive Chairman of Navin Fluorine, expressed enthusiasm for the joint effort to produce sustainable, high-quality specialty chemicals while tackling a significant industry challenge. While Chemours maintains a significant debt-to-equity ratio of 7.2x, InvestingPro data indicates that net income is expected to grow this year, with 10+ additional insights available to subscribers.

The Opteon™ fluid is part of Chemours’ extensive portfolio of data center cooling technologies, which include direct-to-chip and immersion cooling solutions. More information about the product and its benefits can be found on the company’s website, Opteon.com.

Chemours specializes in industrial and specialty chemical products, serving various markets with brands like Opteon™, Freon™, Ti-Pure™, and Teflon™. Navin Fluorine, a prominent Indian fluorochemicals manufacturer, brings its expertise and commitment to sustainability to the partnership.

The agreement aims to bring this innovative technology to market quickly and efficiently, positioning Chemours and Navin Fluorine to meet a critical market need while advancing their respective missions in the specialty chemicals sector. Despite recent market volatility, Chemours maintains an attractive dividend yield of 8.26% and trades at a P/E ratio of 20.8x. For comprehensive analysis and detailed financial metrics, investors can access the full Pro Research Report available on InvestingPro, covering this and 1,400+ other US equities. This partnership is based on a press release statement.

In other recent news, Chemours Company reported significant developments from its annual shareholder meeting. Shareholders elected all twelve director nominees and approved the "say-on-pay" proposal for executive compensation. However, a proposal to eliminate supermajority voting provisions and a policy on biodiversity impact did not pass. PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm with strong shareholder support. In analyst updates, RBC Capital Markets reduced its price target for Chemours from $25.00 to $17.00 while maintaining an Outperform rating, citing demand weakness and tariffs as key factors. Mizuho Securities upgraded Chemours from ’Neutral’ to ’Outperform’ with a price target of $19.00, noting positive developments such as inventory normalization and stabilization in specialty plastics. Additionally, Chemours announced that board member Guillaume Pepy will not seek re-election at the upcoming annual meeting, with no disagreements cited in his decision. These recent developments reflect ongoing changes and strategic considerations within Chemours.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.